Back

Benefits of sotagliflozin across the full range of baseline blood pressure in the SOLOIST-WHF Trial

30 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Heart failure frontiers: from decongestion to advanced therapeutics Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Edan Zitelny

Mount Sinai Fuster Heart Hospital, New York City (United States of America)

7 More presentations in this session

Presentation thumbnail
Natriuretic peptide receptor 1 targeting chimeras for cardiovascular selective degradation of extracellular proteins
Doctor K. Zhang (Wuhan, CN)
Abstract
Presentation thumbnail
Multicenter machine learning based risk assessment model, integrating omics, clinical and patient centred data to prevent recurrent heart failure events
Professor J. Comin-Colet (Barcelona, ES)
Abstract
Presentation thumbnail
Preemptive cardiorenal phenotyping to forecast diuretic resistance in acute heart failure: derivation and internal validation of the strides score
Doctor H. Al Farhan (Baghdad, IQ)
Abstract
Presentation thumbnail
Pre-event guideline-directed optimized medical therapy intensity and in-hospital mortality in heart failure–related cardiogenic shock: insights from the ALT-SHOCK registry
Doctor G. Guarnieri (Milan, IT)
Abstract
Presentation thumbnail
The ACETAZ-HF trial: intravenous furosemide plus oral acetazolamide for rapid decongestion in acute HFrEF and sustained outpatient benefit
Doctor R. Rascon Sabido (Veracruz, MX)
Abstract

Access the full session

Session thumbnail
Heart failure frontiers: from decongestion to advanced therapeutics

The Event

Event poster

ESC Congress 2026

30 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure
20 May 2023
thumbnail
Congress Presentation
Blood pressure effect of semaglutide in patients with hypertension: an individual patient data analysis of randomised controlled trials
25 April 2024
thumbnail
Congress Presentation
Systolic blood pressure and outcome in patients admitted with acute heart failure: a pooled analysis from 4 randomized clinical trials.
14 March 2021
thumbnail
Congress Presentation
Low blood pressure and the effect of SGLT2 inhibitors in heart failure with reduced ejection fraction: data from the China Cardiovascular Association Database-Heart Failure Center Registry
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources